CLASS II Drug recall · Reported 14 Dec 2022 · FDA Enforcement Report

Desmopressin Acetate Tablet, 0.2 mg recalled by RemedyRepack

RemedyRepack is recalling Desmopressin Acetate Tablet, 0.2 mg, distributed in Michigan. The recall was initiated on 5 Dec 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023
Quantity recalled9 boxes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0077-2023
FDA event ID
91263
Recalling firm
RemedyRepack, Indiana, PA
Classification
Class II
Status
Terminated
Recall initiated
5 Dec 2022
FDA classified
7 Dec 2022
Reported
14 Dec 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

5 Dec 2022Recall initiated by company
7 Dec 2022Classified by FDA+2 days
14 Dec 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.

Where it was distributed

Product was distributed to two different customers in MI.

Michigan

Questions about this recall

Why was it recalled?

Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

Which lots are affected?

Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023

Where was it sold?

Product was distributed to two different customers in MI.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from RemedyRepack

All 61

Other Desmopressin recalls

All 13